St. Louis, MO, United States of America

Partha Karmakar

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Partha Karmakar

Introduction

Partha Karmakar is a notable inventor based in St. Louis, Missouri. He has made significant contributions to the field of pharmaceuticals, particularly in the development of near-infrared fluorescent dyes. With a total of three patents to his name, Karmakar's work has the potential to impact various medical applications.

Latest Patents

Karmakar's latest patents include innovative pharmaceutical compositions that comprise effective amounts of cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301) and cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Tyr-OH (LS838). These compositions are designed to include divalent metal ions and pharmaceutically acceptable carriers. Additionally, his patents describe methods for identifying compromised phosphorylated annexin A2 (pANXA2) protein in biological samples, showcasing the practical applications of his research.

Career Highlights

Partha Karmakar is affiliated with Washington University, where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective pharmaceutical solutions that can enhance diagnostic and therapeutic processes.

Collaborations

Karmakar has collaborated with esteemed colleagues such as Samuel I Achilefu and Rui Tang. These partnerships have further enriched his research endeavors and contributed to the advancement of his innovative projects.

Conclusion

Partha Karmakar's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work in developing near-infrared fluorescent dyes is paving the way for advancements in medical diagnostics and treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…